Xi Ai

Identification of Free Fatty Acid Receptor 2 Agonists Using Virtual Screening.

Michael F. Finley, James I. Fells, H. Hoveyda, 2020, Bioorganic & medicinal chemistry letters.

From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9.

Sujata Sharma, J. Lisnock, P. Orth, 2019, Cell chemical biology.

In Vitro Assays for the Discovery of PCSK9 Autoprocessing Inhibitors

J. Gesell, Shirly Pinto, M. Kavana, 2016, Journal of biomolecular screening.

High-Throughput Screening to Identify Small Molecules That Selectively Inhibit APOL1 Protein Level in Podocytes

A. Peier, S. Previs, M. Wildey, 2021, SLAS discovery : advancing life sciences R & D.

Utilizing HaloTag Technology to Track the Fate of PCSK9 from Intracellular vs. Extracellular Sources

D. Wisniewski, B. Hubbard, O. Palyha, 2012, Current chemical genomics.

Live Cell Membranome cDNA Screen: A Novel Homogenous Live Cell Binding Assay to Study Membrane Protein-Ligand Interaction

A. Peier, Elizabeth Smith, Andyun-Fan Liaw, 2019, SLAS discovery : advancing life sciences R & D.

Effects of anacetrapib on plasma lipids, apolipoproteins and PCSK9 in healthy, lean rhesus macaques.

M. Cleary, D. Johns, T. Roddy, 2014, European journal of pharmacology.

C-terminal Loop Mutations Determine Folding and SecretionProperties of PCSK9

D. Johns, T. Vogt, D. Wisniewski, 2016 .

From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9.

Sujata Sharma, P. Orth, J. Shipman, 2021, Cell chemical biology.